Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.

Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page
- Check5 days agoChange DetectedThis updates the website software/version indicator for the study details page (Revision v3.5.3 instead of v3.5.2) without changing the displayed clinical trial content.SummaryDifference0.1%

- Check12 days agoChange Detected- Revision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Hepatocellular carcinoma term and a Genetic and Rare Diseases Information Center resource. Updated site version from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.2 is now displayed. The earlier v3.4.1 notice about government funding and operating status has been removed.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a notice about a lapse in government funding, indicating information may not be up to date and directing users to opm.gov. Updated the page with Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.